Augustus O. Okhamafe

Person

Concord, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
- Patent number 12,076,372
- Issue date Sep 3, 2024
- Biomarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
- Patent number 11,911,446
- Issue date Feb 27, 2024
- Biomarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
- Patent number 11,590,204
- Issue date Feb 28, 2023
- Biomarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of prokaryotic phenylalanine ammonia-lyase variants an...
- Patent number 11,505,790
- Issue date Nov 22, 2022
- Biomarin Pharmaceutical Inc.
- Augustus O. Okhamafe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 11,229,687
- Issue date Jan 25, 2022
- Biomarin Pharmaceutical Inc.
- Thomas Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Variants of C-type natriuretic peptide
- Patent number RE48267
- Issue date Oct 20, 2020
- Biomarin Pharmaceutical Inc.
- Daniel J. Wendt
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 10,758,598
- Issue date Sep 1, 2020
- Biomarin Pharmaceutical Inc.
- Thomas Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
- Patent number 10,646,550
- Issue date May 12, 2020
- Biomarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TPP-1 formulations and methods for treating CLN2 disease
- Patent number 10,279,015
- Issue date May 7, 2019
- Biomarin Pharmaceutical Inc.
- Thomas W. Lester
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of prokaryotic phenylalanine ammonia-lyase variants an...
- Patent number 10,221,408
- Issue date Mar 5, 2019
- Biomarin Pharmaceutical Inc.
- Augustus O. Okhamafe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of C-type natriuretic peptide variants to treat skeletal dysplasia
- Patent number 9,907,834
- Issue date Mar 6, 2018
- Biomarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Variants of C-type natriuretic peptide
- Patent number RE46707
- Issue date Feb 13, 2018
- Biomarin Pharmaceutical Inc.
- Daniel J. Wendt
Information Patent Grant
Manufacture of active highly phosphorylated human N-acetylgalactosa...
- Patent number 9,567,572
- Issue date Feb 14, 2017
- Biomarin Pharmaceutical Inc.
- Vish Koppaka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dry blend formulation of tetrahydrobiopterin
- Patent number 9,216,178
- Issue date Dec 22, 2015
- Biomarin Pharmaceutical Inc.
- Tianwei Chou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antagonist anti-CD40 antibody pharmaceutical compositions
- Patent number 8,945,564
- Issue date Feb 3, 2015
- Novartis AG
- Xiaofeng Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Manufacture of active highly phosphorylated human N-acetylgalactosa...
- Patent number 8,940,513
- Issue date Jan 27, 2015
- Biomarin Pharmaceutical Inc.
- Vish Koppaka
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Manufacture of active highly phosphorylated human N-acetylgalactosa...
- Patent number 8,765,437
- Issue date Jul 1, 2014
- Biomarin Pharmaceutical Inc.
- Vish Koppaka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiper...
- Patent number 8,614,216
- Issue date Dec 24, 2013
- Novartis AG
- Augustus O Okhamafe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variants of C-type natriuretic peptide
- Patent number 8,598,121
- Issue date Dec 3, 2013
- Biomarin Pharmaceutical Inc.
- Daniel J. Wendt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of benzimidazolyl pyridyl ethers and formulations thereof
- Patent number 8,501,785
- Issue date Aug 6, 2013
- Novartis AG
- Rampurna Gullapalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulations for benzimidazolyl pyridyl ethers
- Patent number 8,455,662
- Issue date Jun 4, 2013
- Novartis AG
- Ahmad Hashash
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of a Raf kinase inhibitor
- Patent number 8,324,389
- Issue date Dec 4, 2012
- Novartis AG
- Ahmad Hashash
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of administering tetrahydrobiopterin
- Patent number RE43797
- Issue date Nov 6, 2012
- Biomarin Pharmaceutical Inc.
- Daniel I. Oppenheimer
- 514 - Drug, bio-affecting and body treating compositions
Information Patent Grant
Salts of benzimidazolyl pyridyl ethers and formulations thereof
- Patent number 8,202,998
- Issue date Jun 19, 2012
- Novartis AG
- Rampurna Gullapalli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variants of C-type natriuretic peptide
- Patent number 8,198,242
- Issue date Jun 12, 2012
- Biomarin Pharmaceutical Inc.
- Daniel J. Wendt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of administering tetrahydrobiopterin, associated compositio...
- Patent number 7,947,681
- Issue date May 24, 2011
- Biomarin Pharmaceutical Inc.
- Daniel I. Oppenheimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of prokaryotic phenylalanine ammonia-lyase and methods...
- Patent number 7,790,433
- Issue date Sep 7, 2010
- Biomarin Pharmaceutical Inc.
- Emil D. Kakkis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions of prokaryotic phenylalanine ammonia-lyase and methods...
- Patent number 7,537,923
- Issue date May 26, 2009
- Biomarin Pharmaceutical Inc.
- Emil D. Kakkis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
- Publication number 20240374688
- Publication date Nov 14, 2024
- BioMarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
- Publication number 20240156914
- Publication date May 16, 2024
- BioMarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...
- Publication number 20240035013
- Publication date Feb 1, 2024
- BioMarin Pharmaceutical Inc.
- Augustus O. OKHAMAFE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
- Publication number 20230293637
- Publication date Sep 21, 2023
- BOIMARIN PHARMACEUTICAL INC.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TPP-1 Formulations and Methods for Treating CLN2 Disease
- Publication number 20200353059
- Publication date Nov 12, 2020
- BioMarin Pharmaceutical Inc.
- Thomas Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
- Publication number 20200246433
- Publication date Aug 6, 2020
- BioMarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
- Publication number 20200246434
- Publication date Aug 6, 2020
- BioMarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...
- Publication number 20190345475
- Publication date Nov 14, 2019
- BioMarin Pharmaceutical Inc.
- Augustus O. Okhamafe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TPP-1 Formulations and Methods for Treating CLN2 Disease
- Publication number 20190216905
- Publication date Jul 18, 2019
- BioMarin Pharmaceutical Inc.
- Thomas Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN
- Publication number 20190160070
- Publication date May 30, 2019
- BIOMARIN PHARMACEUTICALS, INC.
- Tianwei Chou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA
- Publication number 20180207239
- Publication date Jul 26, 2018
- BioMarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Variants of C-Type Natriuretic Peptide
- Publication number 20170051033
- Publication date Feb 23, 2017
- BioMarin Pharmaceutical Inc.
- Daniel J. Wendt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA
- Publication number 20170028023
- Publication date Feb 2, 2017
- BioMarin Pharmaceutical Inc.
- Sherry Bullens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIO...
- Publication number 20170000793
- Publication date Jan 5, 2017
- BioMarin Pharmaceutical Inc.
- Daniel I. Oppenheimer
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...
- Publication number 20160362675
- Publication date Dec 15, 2016
- BioMarin Pharmaceutical Inc.
- Augustus O. Okhamafe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TPP-1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE
- Publication number 20160324942
- Publication date Nov 10, 2016
- BioMarin Pharmaceutical Inc.
- Thomas W. Lester
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Variants of C-Type Natriuretic Peptide
- Publication number 20160256553
- Publication date Sep 8, 2016
- BioMarin Pharmaceutical Inc.
- Daniel J. Wendt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Manufacture of Active Highly Phosphorylated Human N-Acetylgalactosa...
- Publication number 20160186149
- Publication date Jun 30, 2016
- BioMarin Pharmaceutical Inc.
- Vish Koppaka
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN
- Publication number 20160074406
- Publication date Mar 17, 2016
- BioMarin Pharmaceutical Inc.
- Tianwei Chou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTAGONIST ANTI-CD40 ANTIBODY PHARMACEUTICAL COMPOSITIONS
- Publication number 20150110783
- Publication date Apr 23, 2015
- XOMA Technology Ltd.
- Xiaofeng Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MANUFACTURE OF ACTIVE HIGHLY PHOSPHORYLATED HUMAN N-ACETYLGALACTOSA...
- Publication number 20140341878
- Publication date Nov 20, 2014
- BioMarin Pharmaceutical Inc.
- Vish Koppaka
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Pharmaceutically Acceptable Salts of Quinolinone Compounds Having I...
- Publication number 20130338171
- Publication date Dec 19, 2013
- Novartis AG
- Shaopei Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIO...
- Publication number 20130237543
- Publication date Sep 12, 2013
- BioMarin Pharmaceutical Inc.
- Daniel I. Oppenheimer
- G01 - MEASURING TESTING
Information Patent Application
DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN
- Publication number 20130108694
- Publication date May 2, 2013
- BioMarin Pharmaceutical Inc.
- Tianwei Chou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...
- Publication number 20130039898
- Publication date Feb 14, 2013
- BioMarin Pharmaceutical Inc.
- Augustus O. Okhamafe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING I...
- Publication number 20130018058
- Publication date Jan 17, 2013
- Shaopei Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Variants of C-type Natriuretic Peptide
- Publication number 20120316114
- Publication date Dec 13, 2012
- BioMarin Pharmaceutical Inc.
- Daniel J. Wendt
- G01 - MEASURING TESTING
Information Patent Application
SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF
- Publication number 20120308651
- Publication date Dec 6, 2012
- Novartis AG
- Rampurna Gullapalli
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMULATIONS OF QUINOLINONES
- Publication number 20120276200
- Publication date Nov 1, 2012
- Joyce Chou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR SYNTHESIZING QUINOLINONE COMPOUNDS
- Publication number 20120277434
- Publication date Nov 1, 2012
- Shaopei Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Augustus O. Okhamafe

Person

Patents Grantslast 30 patents

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

Compositions of prokaryotic phenylalanine ammonia-lyase variants an...

TPP-1 formulations and methods for treating CLN2 disease

Variants of C-type natriuretic peptide

TPP-1 formulations and methods for treating CLN2 disease

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

TPP-1 formulations and methods for treating CLN2 disease

Compositions of prokaryotic phenylalanine ammonia-lyase variants an...

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

Variants of C-type natriuretic peptide

Manufacture of active highly phosphorylated human N-acetylgalactosa...

Dry blend formulation of tetrahydrobiopterin

Antagonist anti-CD40 antibody pharmaceutical compositions

Manufacture of active highly phosphorylated human N-acetylgalactosa...

Manufacture of active highly phosphorylated human N-acetylgalactosa...

Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiper...

Variants of C-type natriuretic peptide

Salts of benzimidazolyl pyridyl ethers and formulations thereof

Formulations for benzimidazolyl pyridyl ethers

Solid forms of a Raf kinase inhibitor

Methods of administering tetrahydrobiopterin

Salts of benzimidazolyl pyridyl ethers and formulations thereof

Variants of C-type natriuretic peptide

Methods of administering tetrahydrobiopterin, associated compositio...

Compositions of prokaryotic phenylalanine ammonia-lyase and methods...

Compositions of prokaryotic phenylalanine ammonia-lyase and methods...

Patents Applicationslast 30 patents

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

TPP-1 Formulations and Methods for Treating CLN2 Disease

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia

COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...

TPP-1 Formulations and Methods for Treating CLN2 Disease

DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN

USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA

Variants of C-Type Natriuretic Peptide

USE OF C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA

METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIO...

COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...

TPP-1 FORMULATIONS AND METHODS FOR TREATING CLN2 DISEASE

Variants of C-Type Natriuretic Peptide

Manufacture of Active Highly Phosphorylated Human N-Acetylgalactosa...

DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN

ANTAGONIST ANTI-CD40 ANTIBODY PHARMACEUTICAL COMPOSITIONS

MANUFACTURE OF ACTIVE HIGHLY PHOSPHORYLATED HUMAN N-ACETYLGALACTOSA...

Pharmaceutically Acceptable Salts of Quinolinone Compounds Having I...

METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIO...

DRY BLEND FORMULATION OF TETRAHYDROBIOPTERIN

COMPOSITIONS OF PROKARYOTIC PHENYLALANINE AMMONIA-LYASE VARIANTS AN...

PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING I...

Variants of C-type Natriuretic Peptide

SALTS OF BENZIMIDAZOLYL PYRIDYL ETHERS AND FORMULATIONS THEREOF

FORMULATIONS OF QUINOLINONES

METHODS FOR SYNTHESIZING QUINOLINONE COMPOUNDS